Login to Your Account

Pharma: Other News To Note

Wednesday, October 2, 2013
• Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, and H. Lundbeck A/S, of Copenhagen, Denmark, said the FDA approved Brintellix (vortioxetine) to treat major depressive disorder in adults.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription